Tobacco addiction and economic efficiency of treating tobacco addiction in patients of the Krasnoyarsk regional oncological dispensary

Smoking tobacco was proved to be the one of the most critical risk factors contributing to the development of malignant neoplasm in the respiratory system. In 2015, lung cancer morbidity rate and the threat in the Krasnoyarsk Region were 1,3 times higher for men and 1,5 times higher for women in comparison to standardized figures per hundred thousand of population in Russia. The economic expenditures associated with diagnostics and treatment of such patients are enormous. That is why the significance of studies in this area is beyond doubt. The goals of this work is the study of the prevalence rate as well as duration and frequency of smoking among patients of the Krasnoyarsk Regional Oncologic Dispensary, calculation of relative and population attributable risks of oncological diseases development and estimation of the economic expenditures associated with smoking in the studied group. Data were collected by using of the questionnaire survey method. 389 patients of the oncologic dispensary were questioned. The data obtained were processed statistically. Relative and population attributable risks were calculated with the help of the corresponding formulas. Data analysis shows that the half (49.9%) ofpatients of the oncologic dispensary have either never smoked, 30% do not smoke now but used to smoke in the past and 20.1% continue smoking. Patients dispensary (65.9% in men and 87.7% - in women). About the half of the patients (41.6%) smoke 11-20 cigarettes a day. Calculations of the population attributable risks show that smoking is the cause of 21.3% of oncological disease incidences, of which lung cancer accounts for 73.7%. The total expenses for health system connected with smoking in oncological diseases in a year made 140 million 527 thousand rubles. These are the expenses that would not have been incurred if there were no impact of the risk factor.

prevalence, duration of smoking, smoking frequency, riskfactor, malignant neoplasm, lung cancer, aggregate costs